Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

Altimmune stock took a huge hit after its liver disease drug, pemvidutide, failed to show strong results in reducing fibrosis ...

Michter’s 2025 Legacy Series features two limited releases: Bomberger’s Declaration Kentucky Straight Bourbon (54% ABV) and ...

Madrigal Pharmaceuticals (NASDAQ:MDGL) and Viking Therapeutics (NASDAQ:VKTX) were among notable gainers on Thursday as ...

Shares of Altimmune tumbled after the company failed to achieve statistical significance on one of the dual primary endpoints in a recent trial evaluating its drug, pemvidutide, for metabolic ...

First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with statistically significant MASH resolution without worsening of fibrosis ...

H.C. Wainwright analyst Patrick Trucchio says the selloff in shares of Altimmune (ALT) on the IMPACT readout appears overdone. The company ...

The clinical-stage biopharmaceutical company reported that the trial met its primary endpoint, with up to 59.1% of participants achieving MASH resolution without worsening of fibrosis in an ...

At the heart of Monsters Are Coming is the city. This bastion of civilisation is under siege by swarms of inky black spider-like monsters, but it’s not going to take this assault lying down. No, the ...

ST. LOUIS — It wouldn’t be a Thursday morning on Show Me St. Louis without Dusty from 93.7 the Bull!

With Russian air defenses engaged and Moscow’s Vnukovo airport restricted, at least 50 UAVs were reportedly downed across ...

Ginger-lemon tea is ideal for those looking for a refreshing drink with health benefits. Boil water and add slices of lemon ...